For the quarter ending 2026-01-31, PBSV made $2,294,966 in revenue. $32,860 in net income. Net profit margin of 1.43%.
| Income Statement | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Revenues | 2,294,966 | 2,430,905.5* | 1,963,083 | 2,417,044 |
| Cost of services | 1,572,592 | 1,610,355.5* | 1,388,821 | 1,598,318 |
| Gross profit | 722,374 | 820,550* | 574,262 | 818,726 |
| Selling, general and administrative expenses | 816,909 | 839,913.5* | 888,139 | 917,048 |
| Loss from operations | -94,535 | -19,363.5* | -313,877 | -98,322 |
| Other income, net | 131,025 | 73,014* | 104,848 | 199,186 |
| Income before income tax | 36,490 | 53,650.5* | -209,029 | 100,864 |
| Income tax expense | 3,630 | -9,232* | 4,779 | 5,511 |
| Net income | 32,860 | 62,882.5 | -204,250 | 95,353 |
| Diluted EPS | 0.001 | 0.003 | 0.009 | 0.004 |
| Basic Average Shares | 22,905,743 | 22,980,061 | 22,927,283 | 22,934,385 |
| Diluted Average Shares | 22,912,954 | 22,988,230 | 22,937,921 | 22,944,408 |
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)